Latest News
24-Nov-2025 Biocon Chief Bats for Dual-Agency Model to Hasten Drug Approvals
21-Nov-2025 ‘Biocon in Very Unique Position Globally as a Biosimilars Leader’
20-Nov-2025 Drug Regulator Proposes Licensing of Marketers to Ensure Quality, Safety
19-Nov-2025 Drug Regulator to Tighten Scrutiny on High-Risk Solvents
18-Nov-2025 Minimum Import Prices for Key Drug Ingredients Likely Soon
  more...
Latest Reports
Oct-25 Q2FY26: Steady sales growth, margin to remain flat - HDFC Securities  
Oct-25 Q2FY26 preview: Bracing for slower growth - ICICI Securities  
Oct-25 A sweeping positive move - Emkay Research  
Sep-25 Scaling capacity ahead of Semaglutide patent expiry - Motilal Oswal  
Aug-25 IPM: 7% value and 2% unit decline in Jul-25 - HDFC Securities  
  more...

Quarterly Summary June-2025
Desc Current Previous Per.Chg
Sales 72470.4 65585.7 10.5
Otherincome 2644.2 1897.0 39.4
Expense 51971.3 49147.6 5.7
RawMaterial 20024.7 18823.0 6.4
StaffCost 11094.3 10095.5 9.9
ExciseDuty 81.0 75.1 7.8
OtherExp 15645.7 15165.0 3.2
Interest 1230.9 1079.5 14.0
GrossProfit 23043.0 18465.4 24.8
Depreciation 2940.4 2761.9 6.5
Tax 4527.1 3667.4 23.4
NetProfit 14847.4 11957.8 24.2
Total.Comp 181 -- --
Source: ETIG Database

Sectoral Companies As on 21 Nov 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 427027.41
Divi's Lab 169199.16
Torrent Phar 124872.51
Cipla 122079.30
Dr.Reddy's 103870.14
Zydus Life 93023.19
Lupin 92660.87
Mankind Phar 92591.04
Aurobindo Ph 70618.53
Alkem Labora 68160.24
Abbott (I) 62808.84
Laurus Labs 52768.15
Glenmark Pha 52070.13
  click here for the complete list